These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 8956997

  • 21. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M.
    Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422
    [Abstract] [Full Text] [Related]

  • 22. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
    Bennett JD, Farlie PG, Watson RJ.
    Oncogene; 1996 Sep 05; 13(5):1073-82. PubMed ID: 8806697
    [Abstract] [Full Text] [Related]

  • 23. Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation.
    Richon VM, Lyle RE, McGehee RE.
    J Biol Chem; 1997 Apr 11; 272(15):10117-24. PubMed ID: 9092557
    [Abstract] [Full Text] [Related]

  • 24. Retinoblastoma-related protein pRb2/p130 and its binding to the B-myb promoter increase during human neuroblastoma differentiation.
    Raschellà G, Tanno B, Bonetto F, Amendola R, Battista T, De Luca A, Giordano A, Paggi MG.
    J Cell Biochem; 1997 Dec 01; 67(3):297-303. PubMed ID: 9361185
    [Abstract] [Full Text] [Related]

  • 25. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R, Cheng E, Smicun Y, Germino J.
    J Exp Med; 2000 Mar 20; 191(6):1005-16. PubMed ID: 10727462
    [Abstract] [Full Text] [Related]

  • 26. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth.
    Sellers WR, Novitch BG, Miyake S, Heith A, Otterson GA, Kaye FJ, Lassar AB, Kaelin WG.
    Genes Dev; 1998 Jan 01; 12(1):95-106. PubMed ID: 9420334
    [Abstract] [Full Text] [Related]

  • 27. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors.
    Kalejta RF, Bechtel JT, Shenk T.
    Mol Cell Biol; 2003 Mar 01; 23(6):1885-95. PubMed ID: 12612064
    [Abstract] [Full Text] [Related]

  • 28. The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction.
    Swenson JJ, Mauser AE, Kaufmann WK, Kenney SC.
    J Virol; 1999 Aug 01; 73(8):6540-50. PubMed ID: 10400750
    [Abstract] [Full Text] [Related]

  • 29. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins.
    Pajovic S, Wong EL, Black AR, Azizkhan JC.
    Mol Cell Biol; 1997 Nov 01; 17(11):6459-64. PubMed ID: 9343408
    [Abstract] [Full Text] [Related]

  • 30. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA.
    Cancer Res; 1997 Jul 01; 57(13):2789-98. PubMed ID: 9205091
    [Abstract] [Full Text] [Related]

  • 31. E2F-4, a new member of the E2F transcription factor family, interacts with p107.
    Ginsberg D, Vairo G, Chittenden T, Xiao ZX, Xu G, Wydner KL, DeCaprio JA, Lawrence JB, Livingston DM.
    Genes Dev; 1994 Nov 15; 8(22):2665-79. PubMed ID: 7958924
    [Abstract] [Full Text] [Related]

  • 32. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
    Cobrinik D, Whyte P, Peeper DS, Jacks T, Weinberg RA.
    Genes Dev; 1993 Dec 15; 7(12A):2392-404. PubMed ID: 8253385
    [Abstract] [Full Text] [Related]

  • 33. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes.
    Fattaey AR, Harlow E, Helin K.
    Mol Cell Biol; 1993 Dec 15; 13(12):7267-77. PubMed ID: 8246949
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr virus EBNA-LP and transcription regulation properties of pRB, p107 and p53 in transfection assays.
    Inman GJ, Farrell PJ.
    J Gen Virol; 1995 Sep 15; 76 ( Pt 9)():2141-9. PubMed ID: 7561751
    [Abstract] [Full Text] [Related]

  • 35. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM, Schneider-Broussard R, Philhower JL, Johnson DG.
    Mol Carcinog; 1998 Jul 15; 22(3):190-8. PubMed ID: 9688145
    [Abstract] [Full Text] [Related]

  • 36. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S, Nath N, Adlam M, Chellappan S.
    Oncogene; 1999 Jun 10; 18(23):3501-10. PubMed ID: 10376528
    [Abstract] [Full Text] [Related]

  • 37. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter.
    Stiegler P, De Luca A, Bagella L, Giordano A.
    Cancer Res; 1998 Nov 15; 58(22):5049-52. PubMed ID: 9823308
    [Abstract] [Full Text] [Related]

  • 38. Role of pRb-related proteins in simian virus 40 large-T-antigen-mediated transformation.
    Zalvide J, DeCaprio JA.
    Mol Cell Biol; 1995 Oct 15; 15(10):5800-10. PubMed ID: 7565733
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1.
    Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG.
    Mol Cell Biol; 1998 Jun 15; 18(6):3212-22. PubMed ID: 9584162
    [Abstract] [Full Text] [Related]

  • 40. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D, Cannella D, Boulaire J, Fitzgerald P, Fotedar A, Fotedar R.
    Oncogene; 1999 May 27; 18(21):3290-302. PubMed ID: 10359535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.